NCT05741008View on ClinicalTrials.gov

Clincal Study of Reduced Target Radiotherapy in Nasopharyngeal Carcinoma

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

March 25, 2025

Study Completion Date

March 25, 2025

Conditions
Toxicity Due to RadiotherapyNasopharyngeal Carcinoma
Interventions
RADIATION

Target range

Compared with conventional radiotherapy, the target dose is unchanged and the CTV2 volume is reduced.

Trial Locations (1)

650032

First Affiliated Hospital of Kunming Medical University, Kunming

All Listed Sponsors
lead

First Affiliated Hospital of Kunming Medical University

OTHER